Analogs of Staurosporine
Data up to Jan 2025
Total Citations Per Year
Abstract
References (59)
The retinoblastoma protein and cell cycle control
1995 • 4,873 citations
Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters.
1982 • 4,786 citations
Intracellular Signaling by Hydrolysis of Phospholipids and Activation of Protein Kinase C
1992 • 4,480 citations
ANIMAL CELL CYCLES AND THEIR CONTROL
1992 • 1,239 citations
A new alkaloid AM-2282 of Streptomyces origin taxonomy, fermentation, isolation and preliminary characterization.
1977 • 659 citations
UCN-01: a Potent Abrogator of G2 Checkpoint Function in Cancer Cells With Disrupted p53
1996 • 451 citations
Protein kinase C isozymes and substrates
1996 • 440 citations
A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and In vitro anti‐proliferative as well as In vivo anti‐tumor activity
1989 • 414 citations
Potent and Specific Inhibitors of Protein Kinase C of Microbial Origin
1990 • 262 citations
Phorbol esters induce multidrug resistance in human breast cancer cells.
1988 • 241 citations
The epsilon isoform of protein kinase C is an oncogene when overexpressed in rat fibroblasts.
1993 • 222 citations
Enhancement of cisplatin-induced cytotoxicity by 7-hydroxystaurosporine (UCN-01), a new G2-checkpoint inhibitor.
1996 • 221 citations
Elevated protein kinase C expression in human breast tumor biopsies relative to normal breast tissue.
1989 • 211 citations
The protein kinase C inhibitors Ro 318220 and GF 109203X are equally potent inhibitors of MAPKAP kinase‐1β (Rsk‐2) and p70 S6 kinase
1997 • 206 citations
UCN-01, a selective inhibitor of protein kinase C from Streptomyces.
1987 • 189 citations
Antitumor activity of UCN-01, a selective inhibitor of protein kinase C, in murine and human tumor models.
1991 • 187 citations
Characterization of Phosphorylation-defective Mutants of Human P-glycoprotein Expressed in Mammalian Cells
1996 • 169 citations
UCN-01 and UCN-02, new selective inhibitors of protein kinase C. II. Purification, physico-chemical properties, structural determination and biological activities.
1989 • 156 citations
G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells.
1997 • 155 citations
Transfection with Protein Kinase Cα Confers Increased Multidrug Resistance to MCF-7 Cells Expressing P-Glycoprotein
1991 • 146 citations
Increased expression of cyclin D1 in a murine mammary epithelial cell line induces p27kip1, inhibits growth, and enhances apoptosis.
1996 • 145 citations
Apoptosis in 7-hydroxystaurosporine-treated T lymphoblasts correlates with activation of cyclin-dependent kinases 1 and 2.
1995 • 137 citations
Cell cycle arrest and growth inhibition by the protein kinase antagonist UCN-01 in human breast carcinoma cells.
1993 • 133 citations
Protein Kinase C-mediated Phosphorylation Does Not Regulate Drug Transport by the Human Multidrug Resistance P-glycoprotein
1996 • 121 citations
Enhancement of antitumor activity of mitomycin C in vitro and in vivo by UCN-01, a selective inhibitor of protein kinase C
1993 • 119 citations
Altered protein kinase C activity in biopsies of human colonic adenomas and carcinomas.
1991 • 117 citations
UCN-01, 7-Hydroxyl-staurosporine, Inhibits Kinase Activity of Cyclin-Dependent Kinases and Reduces the Phosphorylation of the Retinoblastoma Susceptibility Gene Product in A549 Human Lung Cancer Cell Line
1996 • 117 citations
Induction of apoptosis in chronic lymphocytic leukemia cells and its prevention by phorbol ester
1992 • 110 citations
UCN-01 and UCN-02, new selective inhibitors of protein kinase C. I. Screening, producing organism and fermentation.
1989 • 107 citations
7-Hydroxystaurosporine (UCN-01) Induces Apoptosis in Human Colon Carcinoma and Leukemia Cells Independently of p53
1997 • 89 citations
Activation of protein kinase C subtypes α, γ, δ, ϵ, ζ, and η by tumor-promoting and nontumor-promoting agents
1997 • 87 citations
Expression of the antisense cDNA for protein kinase C alpha attenuates resistance in doxorubicin-resistant MCF-7 breast carcinoma cells.
1993 • 79 citations
UCN‐01, an anti‐tumor drug, is a selective inhibitor of the conventional PKC subfamily
1995 • 78 citations
How does p21ras transform cells?
1991 • 75 citations
Comparison of ability of protein kinase C inhibitors to arrest cell growth and to alter cellular protein kinase C localisation
1995 • 75 citations
Blocking of glioma proliferation in vitro and in vivo and potentiating the effects of BCNU and cisplatin: UCN-01, a selective protein kinase C inhibitor
1996 • 74 citations
7-Hydroxystaurosporine (UCN-01) causes redistribution of proliferating cell nuclear antigen and abrogates cisplatin-induced S-phase arrest in Chinese hamster ovary cells.
1997 • 74 citations
The protein kinase C inhibitor CGP 41251, a staurosporine derivative with antitumor activity, reverses multidrug resistance
1994 • 73 citations
Differential inhibition of the epidermal growth factor-, platelet-derived growth factor-, and protein kinase C-mediated signal transduction pathways by the staurosporine derivative CGP 41251.
1992 • 72 citations
Expression pattern of alpha-protein kinase C in human astrocytomas indicates a role in malignant progression.
1992 • 70 citations
Structures of staurosporine bound to CDK2 and cAPK – new tools for structure-based design of protein kinase inhibitors
1997 • 64 citations
Comparison of staurosporine and four analogues: their effects on growth, rhodamine 123 retention and binding to P-glycoprotein in multidrug-resistant MCF-7/Adr cells
1996 • 62 citations
Inhibitory activity and selectivity of staurosporine derivatives towards protein kinase C
1994 • 56 citations
Differential inhibition of cytosolic and membrane‐derived protein kinase C activity by staurosporine and other kinase inhibitors
1995 • 46 citations
Co-ordinate loss of protein kinase C and multidrug resistance gene expression in revertant MCF-7/Adr breast carcinoma cells
1997 • 37 citations
Differing Effects of Staurosporine and UCN-01 on RB Protein Phosphorylation and Expression of Lung Cancer Cell Lines
1996 • 35 citations
Signal transduction for proliferation of glioma cells in vitro occurs predominantly through a protein kinase C-mediated pathway
1996 • 35 citations
Antitumor Effect of CGP41251, a New Selective Protein Kinase C Inhibitor, on Human Non-Small Cell Lung Cancer Cells
1996 • 34 citations
Chemosensitization of cancer cells by the staurosporine derivative CGP 41251 in association with decreased P-glycoprotein phosphorylation
1997 • 31 citations
Differential effects of staurosporine analogues on cell cycle, growth and viability in A549 cells
1996 • 31 citations
Anticancer drugs acting against signaling pathways
1995 • 26 citations
Inhibition of the growth of glioblastomas by CGP 41251, an inhibitor of protein kinase C, and by a phorbol ester tumor promoter.
1996 • 26 citations
Characterisation of novel human lung carcinoma cell lines selected for resistance to anti-neoplastic analogues of staurosporine
1997 • 20 citations
Effects of protein kinase C inhibitor, staurosporine derivative CGP 41 251, on cell cycle, DNA synthesis and drug uptake in neoplastic cell lines
1995 • 18 citations
Protein kinase inhibitor-induced alterations of drug uptake, cell cycle and surface antigen expression in human multidrug-resistant (Pgp and MRP) promyelocytic leukemia HL-60 cells
1997 • 17 citations
Stimulation of 1-(beta-D-arabinofuranosyl)cytosine (AraC)-induced apoptosis in the multidrug resistant human promyelocytic leukemia cell lines with protein kinase inhibitors.
1996 • 14 citations
Effects of the new selective protein kinase C inhibitor 4'-N-benzoyl staurosporine on cell cycle distribution and growth inhibition in human small cell lung cancer cells.
1996 • 14 citations
Disposition in mice of 7-hydroxystaurosporine, a protein kinase inhibitor with antitumor activity
1994 • 13 citations
Deleted Work
1955 • 0 citations